Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022

SELL
$12.16 - $19.42 $170,081 - $271,627
-13,987 Reduced 63.5%
8,040 $98,000
Q1 2022

Apr 27, 2022

BUY
$14.08 - $27.63 $224,787 - $441,112
15,965 Added 263.36%
22,027 $419,000
Q4 2021

Jan 31, 2022

SELL
$26.55 - $40.57 $64,171 - $98,057
-2,417 Reduced 28.51%
6,062 $161,000
Q3 2021

Nov 03, 2021

SELL
$39.27 - $72.94 $47,084 - $87,455
-1,199 Reduced 12.39%
8,479 $348,000
Q1 2021

Apr 29, 2021

SELL
$39.71 - $90.58 $78,824 - $179,801
-1,985 Reduced 17.02%
9,678 $406,000
Q4 2020

Jan 28, 2021

SELL
$27.07 - $84.35 $23,577 - $73,468
-871 Reduced 6.95%
11,663 $818,000
Q3 2020

Oct 29, 2020

BUY
$28.06 - $37.16 $62,012 - $82,123
2,210 Added 21.41%
12,534 $352,000
Q2 2020

Jul 24, 2020

SELL
$18.5 - $34.34 $17,057 - $31,661
-922 Reduced 8.2%
10,324 $305,000
Q1 2020

Apr 29, 2020

SELL
$14.88 - $32.78 $32,765 - $72,181
-2,202 Reduced 16.37%
11,246 $223,000
Q3 2019

Oct 28, 2019

SELL
$22.49 - $26.81 $32,430 - $38,660
-1,442 Reduced 9.68%
13,448 $306,000
Q2 2019

Jul 30, 2019

BUY
$20.48 - $27.76 $304,947 - $413,346
14,890 New
14,890 $368,000
Q3 2018

Nov 05, 2018

SELL
$27.65 - $38.39 $264,085 - $366,662
-9,551 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$31.4 - $41.01 $299,901 - $391,686
9,551 New
9,551 $342,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.